3rd Year BSc Project: “The development of a physiological relevant gastrointestinal human–microbe interface in a novel dual-flow bioreactor.”
The human microbiome consists of more than 1000 different bacterial species that play essential roles in growth and differentiation of the healthy GI-tract, protection against pathogens, and resistance to cancer. Dysbiosis in the gut has been linked to several conditions including diabetes, colorectal cancer and multiple sclerosis. Previous research has focused more on understanding how the bacterial imbalance impacts on disease, yet the way commensal bacteria influence normal development at a cellular level remains largely elusive. This study aims to develop a physiologically-relevant gastrointestinal human–microbiome interface in a dynamic flow bioreactor by co-culturing Caco-2 and HT29-MTX cells with commensal bacterial strains.
The bioreactor emulates the in vivo peristaltic flow, continuously supplying nutrients and oxygen to the apical and basal sides of the membrane. It was found that the addition of laminar flow better recapitulates the physiological events that occur in healthy GI-tract and may yield more accurate results in vitro. The results show that the dual-flow bioreactor can increase cell viability over time when the flow applied is 150 µl/min or below. This model may reveal new insights into host–microbe molecular interactions and has high potential for breakthroughs in the development of a physiologically realistic GI-tract model.
Author: Oana Voloaca
Supervisors: Dr Nikki Jordan Mahy and Dr Mel Lacey
Figure 9. EVOS imaging of the Caco-2/HT29MTX co-cultures grown under static or flow conditions for 7 days after Hoechst/Propidium Iodide staining. Viable cells in interphase are labelled with a blue fluorescent dye. Apoptotic cells were labelled with a red fluorescent dye. The figure compares the degree of apoptosis for three different regions (125 µm) of one insert with cells cultured under static conditions (top) and one insert with cells grown under flow conditions (bottom). A close up of the cells is shown on the right side of the original pictures. Higher numbers of viable and apoptotic cells are visible for the static cultures. Considerable differences between cellular distributions across the membrane of the static co-cultures can be seen in the top images.
Quasi Vivo®, commercially available and used in 70+ labs worldwide, getting started is easy and cost effective!
Address: Kirkstall Ltd
3 Aspen Court
Centurion Business Park
Phone: + 44 (0) 1709 361 241
Business Hours: Monday to Friday 8:00am-5:00pm (GMT)